Publicacións en colaboración con investigadores/as de Helsinki University Central Hospital (5)

2020

  1. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  2. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

2008

  1. Levosimendan in the treatment of AHF: Lessons from surveys and clinical trials

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 228-233

  2. Levosimendan: A decade of experience in Europe built on years of evidence

    European Journal of Heart Failure, Supplement, Vol. 7, Núm. SUPPL. 2, pp. 234-243